COVID-19

COVID: Inhalable and nasal vaccines could offer more durable protection than regular shots

Several mucosal vaccine candidates are being explored in pre-clinical and clinical trials. Image: Unsplash

Sheena Cruickshank

Professor in Biomedical Sciences, University of Manchester

Share:

Our Impact
The Big Picture
Explore and monitor how COVID-19 is affecting economies, industries and global issues
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale

Stay up to date:

COVID-19

Have you read?

Mucosal vaccines could make a big difference for people with needle phobias
Mucosal vaccines could make a big difference for people with needle phobias Image: CDC

Discover

How has the Forum navigated the global response to COVID-19?

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:

COVID-19VaccinationPandemic Preparedness and ResponseGlobal Health

Share:

Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Labour shortages have risen across OECD countries, here's how to plug the gaps

Emilia Soldani, Orsetta Causa, Nhung Luu and Michael Abendschein

December 2, 2022

About Us
Events
Media
Partners & Members
Language Editions

Privacy Policy & Terms of Service

© 2022 World Economic Forum